Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Party drugs: properties, prevalence, patterns, and problems.

Jane Carlisle Maxwell1

  • 1The Gulf Coast Addiction Technology Transfer Center, The School of Social Work, The University of Texas at Austin, Austin, Texas 78703, USA. jcmaxwell@mail.utexas.edu

Substance Use & Misuse
|July 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Health Characteristics of Prescription Opioid Use, Misuse, and Use Disorders Among U.S. Adolescents.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2020
Same author

Is Cocaine Coming Back? A Commentary.

Substance use & misuse·2019
Same author

The Changing Face of Synthetic Cannabinoids in Texas.

Journal of psychoactive drugs·2018
Same author

Self-reported substance use in Iraq: findings from the Iraqi National Household Survey of Alcohol and Drug Use, 2014.

Addiction (Abingdon, England)·2017
Same author

Can progress in reducing alcohol-impaired driving fatalities be resumed? Results of a workshop sponsored by the Transportation Research Board, Alcohol, Other Drugs, and Transportation Committee (ANB50).

Traffic injury prevention·2016
Same author

What Do We Know Now About the Impact of the Laws Related to Marijuana?

Journal of addiction medicine·2016
Same journal

Mistaken Identity: A Prevalence Study of Bromazolam in the American Great Lakes Region.

Substance use & misuse·2026
Same journal

Autistic Trait Dimensions and Alcohol Use in College Attending Emerging Adults.

Substance use & misuse·2026
Same journal

Social Network Characteristics as Predictors of Opioid Use Disorder Treatment Utilization among People Who Use Drugs with Hepatitis C Infections in Baltimore, MD.

Substance use & misuse·2026
Same journal

Ethnicity, Gender, and Perceptions of Alcohol Users: A Vignette Study.

Substance use & misuse·2026
Same journal

Explicit and Implicit Cannabis Harm Perceptions in Relation to Cannabis Use Across Sexual Minority and Heterosexual College Students.

Substance use & misuse·2026
Same journal

Adolescent Romantic Breakup and Substance Use Among Emerging Adults in Delhi-NCR, India.

Substance use & misuse·2026
See all related articles

This review examines club drugs like MDMA, GHB, ketamine, and Rohypnol, highlighting their varied effects and the need for updated treatment protocols. Further research is crucial to combat misinformation and develop effective interventions for these party drugs.

Area of Science:

  • Toxicology
  • Pharmacology
  • Public Health

Background:

  • Club drugs, including MDMA, GHB, ketamine, and Rohypnol, are frequently associated with rave and dance party settings.
  • Despite early identification, comprehensive scientific data on these substances remains limited.
  • Existing research on club drug effects is often constrained by human subject limitations, impacting rigor.

Purpose of the Study:

  • To review and synthesize recent literature on party/club drugs from 2002 to early 2005.
  • To highlight the evolving scientific understanding of these substances.
  • To identify the need for evidence-based treatment protocols.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of data on drug properties, user demographics, and settings.

Related Experiment Videos

  • Examination of adverse effects and acute care requirements.

    • Main Results:

    • Each club drug (MDMA, GHB, ketamine, Rohypnol) exhibits distinct pharmacological properties, user profiles, and associated risks.
    • Adverse effects vary significantly, necessitating tailored acute care strategies.
    • Scientific information and toxicological identification methods are still developing.

    Conclusions:

    • There is a critical need for more rigorous research into the short- and long-term effects of club drugs.
    • The proliferation of online misinformation underscores the urgency for evidence-based data.
    • Development of evaluated, research-driven chemical dependency treatment protocols for each drug is essential.